- Home
- JRSH vs ACHL Comparison
JRSH vs ACHL Comparison
Compare JRSH & ACHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JRSH
- ACHL
- Stock Information
- Founded
- JRSH 2016
- ACHL 2016
- Country
- JRSH United States
- ACHL United Kingdom
- Employees
- JRSH N/A
- ACHL N/A
- Industry
- JRSH Apparel
- ACHL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- JRSH Consumer Discretionary
- ACHL Health Care
- Exchange
- JRSH Nasdaq
- ACHL Nasdaq
- Market Cap
- JRSH 36.5M
- ACHL 40.4M
- IPO Year
- JRSH 2018
- ACHL 2021
- Fundamental
- Price
- JRSH $3.30
- ACHL $1.05
- Analyst Decision
- JRSH
- ACHL Hold
- Analyst Count
- JRSH 0
- ACHL 3
- Target Price
- JRSH N/A
- ACHL $2.83
- AVG Volume (30 Days)
- JRSH 13.9K
- ACHL 142.6K
- Earning Date
- JRSH 11-12-2024
- ACHL 11-14-2024
- Dividend Yield
- JRSH 6.06%
- ACHL N/A
- EPS Growth
- JRSH N/A
- ACHL N/A
- EPS
- JRSH N/A
- ACHL N/A
- Revenue
- JRSH $130,270,418.00
- ACHL N/A
- Revenue This Year
- JRSH $23.86
- ACHL N/A
- Revenue Next Year
- JRSH $10.89
- ACHL N/A
- P/E Ratio
- JRSH N/A
- ACHL N/A
- Revenue Growth
- JRSH N/A
- ACHL N/A
- 52 Week Low
- JRSH $2.68
- ACHL $0.63
- 52 Week High
- JRSH $3.46
- ACHL $1.76
- Technical
- Relative Strength Index (RSI)
- JRSH 71.44
- ACHL 60.22
- Support Level
- JRSH $2.93
- ACHL $0.99
- Resistance Level
- JRSH $3.46
- ACHL $1.12
- Average True Range (ATR)
- JRSH 0.12
- ACHL 0.04
- MACD
- JRSH 0.03
- ACHL -0.00
- Stochastic Oscillator
- JRSH 71.05
- ACHL 54.84
About JRSH Jerash Holdings (US) Inc.
Jerash Holdings (US) Inc along with its subsidiaries is a manufacturer and exporter of customized, ready-made sport and outerwear from knitted fabric from its production facilities in Jordan. The company manufactures for retailers namely Walmart, Costco, Sears, Hanes, Columbia, Land's End, VF Corporation, and Philip-Van Heusen which owns brands such as The North Face, Nautica, Timberland, Wrangler, Lee, Jansport, Calvin Klein, Tommy Hilfiger, IZOD, Speedo etc. It derives its revenue from the manufacturing and sales of outerwear in the United States. The company's product offering consists of jackets, polo shirts, crew neck shirts, pants, and shorts made from knitted fabric. Geographically, the company generates maximum revenue from the United States.
About ACHL Achilles Therapeutics plc
Achilles Therapeutics PLC is a biopharmaceutical company. It is developing AI-powered precision T-cell therapies targeting clonal neoantigens to treat solid tumors. The company has two ongoing trials, the CHIRON trial in patients with non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.